Magnolia NeuroSciences is based in Seattle. It has raised $31M in total funding. Latest round: Series A.
Magnolia NeuroSciences is based in Seattle. Magnolia NeuroSciences has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2018. The round record for Magnolia NeuroSciences runs through 2018; nothing later has been disclosed. Investors on record include 180 Degree Capital, AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, ELI Lilly And Company, Innovate NY Fund and 5 others. 11 distinct backers are named across the disclosed rounds.
Magnolia NeuroSciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Seattle below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026